| 000 | 01871 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514070357.0 | ||
| 264 | 0 | _c20031003 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.103.052167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, Neela | |
| 245 | 0 | 0 |
_aA selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 2003 |
||
| 300 |
_a838-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
| 650 | 0 | 4 |
_aPropionates _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 700 | 1 | _aSun, Li | |
| 700 | 1 | _aMoshinsky, Deborah | |
| 700 | 1 | _aChen, Hui | |
| 700 | 1 | _aLeahy, Kathleen M | |
| 700 | 1 | _aLe, Phuong | |
| 700 | 1 | _aMoss, Katherine G | |
| 700 | 1 | _aWang, Xueyan | |
| 700 | 1 | _aRice, Audie | |
| 700 | 1 | _aTam, Danny | |
| 700 | 1 | _aLaird, A Douglas | |
| 700 | 1 | _aYu, Xiaoming | |
| 700 | 1 | _aZhang, Qingling | |
| 700 | 1 | _aTang, Cho | |
| 700 | 1 | _aMcMahon, Gerald | |
| 700 | 1 | _aHowlett, Anthony | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 306 _gno. 3 _gp. 838-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.103.052167 _zAvailable from publisher's website |
| 999 |
_c12552704 _d12552704 |
||